BridgeBio · 1 day ago
Director, Biostatistics
Maximize your interview chances
BiotechnologyHealth Care
Growth OpportunitiesH1B Sponsor Likely
Insider Connection @BridgeBio
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Leads statistical and statistical programming team at the product level
Provides statistical input to strategic planning, study design, protocol development, sample size calculation, Case Report Form, Results Interpretation, clinical study report, and addressing questions from regulatory agencies. Develop and maintain SAPs, including the derived variables, the templates of statistical tables, figures, and listings
Provides guidance to study team on all aspects of statistical activities; collaborates closely with data manager to ensure high-quality data
Works collaboratively with Clinical Development, Clinical Operations, Clinical Data Managers, Pharmacovigilance & Epidemiology, Regulatory, Project Management, Translational Medicine, and other staff and vendors to meet project deliverables and timelines
CRO / Vendor Oversight: Establishes procedures through regular interaction, setting expectations on deliverables and timelines to guide CRO biostatisticians and statistical programmers. Ensures deliverables are accurate and delivered according to the timelines
Global Health Authority Interaction: Contributes to documents submitted to Health Authorities globally by providing input for the interaction or by writing the interaction document. May participate in meetings or teleconferences with Health Authorities
Coordinate with internal and external team members to prepare the statistical analyses for IB, DSUR updates, periodic safety updates, and other ad hoc safety analyses; participate in cross-functional study-related activities; attend team meetings
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
PhD in statistics or biostatistics and 8+ years relevant experience in the pharmaceutical/biotechnology industry or MS in Biostatistics or Statistics and 11+ years relevant experience in the pharmaceutical/biotechnology industry
NDA submission experiences
Strong knowledge of statistical methodologies, current drug development trends, and regulatory environments.
Strong analytical and problem-solving skills; able to identify and investigate issues and causes independently and formulate potential solutions
Able to prioritize multiple tasks, develop instructions and manage vendors in completing the deliverables with high quality according to timelines, and provide recommendations to improve process
Excellent programming skills in SAS and/or R
Excellent oral and written communication skills
Ability to work as a part of a cross-functional team in a fast-paced environment and to work collaboratively with external partners and vendors
Benefits
Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
Flexible PTO
Rapid career advancement for strong performers
Access to learning and development resources to help you get in the best professional shape of your life
Commitment to Diversity, Equity & Inclusion
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
H1B Sponsorship
BridgeBio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (2)
2022 (3)
2021 (1)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$3.85BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2024-03-05Post Ipo Equity· $250M
2024-01-18Post Ipo Debt· $1.25B
2023-09-22Post Ipo Equity· $250M
Recent News
Morningstar, Inc.
2024-12-17
StreetInsider.com
2024-12-16
Company data provided by crunchbase